Article Sidebar
Article Details
Issue
Section
Articles
Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Tarik Chekrine
Service d’Oncologie-Radiothérapie, Centre Hospitalier Universitaire Ibn Rochd, 1 quartier des hôpitaux, 20360 Casablanca, MarocHassan Jouhadi
Service d’Oncologie-Radiothérapie, Centre Hospitalier Universitaire Ibn Rochd, 1 quartier des hôpitaux, 20360 Casablanca, MarocZineb Bouchbika
Service d’Oncologie-Radiothérapie, Centre Hospitalier Universitaire Ibn Rochd, 1 quartier des hôpitaux, 20360 Casablanca, MarocNadia Benchakroun
Service d’Oncologie-Radiothérapie, Centre Hospitalier Universitaire Ibn Rochd, 1 quartier des hôpitaux, 20360 Casablanca, MarocNezha Tawfiq
Service d’Oncologie-Radiothérapie, Centre Hospitalier Universitaire Ibn Rochd, 1 quartier des hôpitaux, 20360 Casablanca, MarocSouha Sahraoui
Service d’Oncologie-Radiothérapie, Centre Hospitalier Universitaire Ibn Rochd, 1 quartier des hôpitaux, 20360 Casablanca, MarocAbdelatif Benider
Service d’Oncologie-Radiothérapie, Centre Hospitalier Universitaire Ibn Rochd, 1 quartier des hôpitaux, 20360 Casablanca, MarocMain Article Content
Gastrointestinal stromal tumour of the rectum: a report of two cases
Tarik Chekrine
Hassan Jouhadi
Zineb Bouchbika
Nadia Benchakroun
Nezha Tawfiq
Souha Sahraoui
Abdelatif Benider
Abstract
Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the gastrointestinal tract in adults, although rectal localisation of these tumours is very rare. We report here two cases of rectal stromal tumours in a 77-year-old woman and a 65-year-old man, confirmed by histology and immunohistochemistry. Surgery for rectal GIST patients is the standard treatment and adjuvant imatinib, a tyrosine kinase inhibitor, is indicated for GISTs with a high risk of malignancy, as well as in the case of metastatic or unresectable tumours.
Pan African Medical Journal 2012; 12:19
Pan African Medical Journal 2012; 12:19